|
Volumn 177, Issue 4, 2006, Pages 2036-
|
Comment on "Cutting edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4 +CD25+ T regulatory cells" [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CD4 ANTIGEN;
INTERLEUKIN 2 RECEPTOR ALPHA;
TRANSCRIPTION FACTOR FOXP3;
INTERLEUKIN 2 RECEPTOR;
MONOCLONAL ANTIBODY;
ALLERGIC ENCEPHALOMYELITIS;
ANIMAL CELL;
ANTIGEN EXPRESSION;
AUTOIMMUNITY;
CD4+ CD25+ T LYMPHOCYTE;
CELL CLONE;
DOWN REGULATION;
FLUORESCENCE ACTIVATED CELL SORTING;
INJECTION;
LETTER;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ANIMAL;
CYTOLOGY;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE DEPLETION;
NOTE;
REGULATORY T LYMPHOCYTE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE DEPLETION;
RATS;
RECEPTORS, INTERLEUKIN-2;
T-LYMPHOCYTES, REGULATORY;
|
EID: 33746918744
PISSN: 00221767
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (26)
|
References (7)
|